Showing results (31-40 of 127) with videos related to
Sort By:
Pageof 13
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2013
A framework for understanding quality of life in individuals without capacityJeff Round, Elizabeth L Sampson, Louise JonesPharmacoeconomics|November 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit FrontierChristopher McCabe, Giovanni Tramonti, Andrew Sutton, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual ModelDaniel D H Howdon, James R S Lomas, Mike PauldenPharmacoeconomics|August 23, 2014
Some inconsistencies in NICE's consideration of social valuesMike Paulden, James F O'Mahony, Anthony J Culyer, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 5, 2021
Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trialNathan S McClure, Mike Paulden, Arto Ohinmaa, et al.Economics and Human Biology|May 23, 2020
The health and financial impacts of a sugary drink tax across different income groups in CanadaKai-Erh Kao, Amanda C Jones, Arto Ohinmaa, et al.Pharmacoeconomics|December 17, 2019
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net BenefitChristopher McCabe, Mike Paulden, Isaac Awotwe, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 9, 2022
Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount RatesAnkur Pandya, Mike Paulden, Jinyi Zhu, et al.British Journal of Clinical Pharmacology|August 19, 2010
Cost-effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologistsRichard Edlin, Jeff Round, Claire Hulme, et al.Disability and Rehabilitation|October 31, 2020
Quality of reporting of economic evaluations in rehabilitation research: a systematic reviewJulie Flemming, Dagmara Chojecki, Lisa Tjosvold, et al.Pageof 13